Related Experiment Video
Updated: Dec 25, 2025
07:51
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
702
Canadian Guidelines on Cannabis Use Disorder Among Older Adults
Jonathan R Bertram1,2, Amy Porath3, Dallas Seitz4
1Centre for Addiction and Mental Health, Toronto, ON.
Canadian Geriatrics Journal : CGJ
|April 1, 2020
Summary
Cannabis Use Disorder (CUD) is a growing concern in older adults. Guidelines offer strategies for prevention, identification, and treatment of CUD in this population.
Area of Science:
- Geriatric medicine
- Addiction psychiatry
- Public health
Background:
- Cannabis Use Disorder (CUD) presents a unique and evolving challenge for the older adult population.
- Increased cannabis use, both recreational and medical, among seniors necessitates attention to potential adverse outcomes.
Purpose of the Study:
- To present evidence-based guidelines for the prevention, identification, assessment, and treatment of CUD in older adults.
- To equip clinicians with strategies for managing CUD in the geriatric population.
Main Methods:
- Development of evidence-based guidelines by the Canadian Coalition for Seniors' Mental Health.
- Financial support and collaboration with Health Canada.
Main Results:
- Guidelines cover comprehensive management of CUD, from prevention to treatment.
- Focus on the specific needs and presentation of CUD in older adults.
Conclusions:
- Clinicians must be vigilant in detecting CUD in older adults, regardless of use type (recreational or medical).
- Awareness of CUD prevention and management strategies is crucial for this demographic.
- Full guidelines are available at www.ccsmh.ca for clinical application.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
168
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
168
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
141
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
141
01:24Substance Use Disorders Affecting Sleep
338
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
338
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
190
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
190
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
169
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
169
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
142
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
142